Lysogene is a biopharmaceutical gene therapy company specializing in treatments for central nervous system (CNS) diseases with lead programs in neurodegenerative lysosomal storage disorders.
We use cookies to ensure that we give you the best experience on our website. By accepting, you are agreeing to our use of cookies per our privacy policy.AcceptDeclinePrivacy policy